| [1] |
FOGARTY H, DOHERTY D, O'DONNELL J S. New developments in von Willebrand disease[J]. Br J Haematol, 2020, 191(3):329-339.
DOI
URL
|
| [2] |
LEEBEEK F W, EIKENBOOM J C. Von Willebrand's disease[J]. N Engl J Med, 2016, 375(21):2067-2080.
DOI
URL
|
| [3] |
LAFFAN M A, LESTER W, O'DONNELL J S, et al. The diagnosis and management of von Willebrand disease:a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology[J]. Br J Haematol, 2014, 167(4):453-465.
DOI
URL
|
| [4] |
王兆钺. 血管性血友病诊治进展[J]. 中国实用内科杂志, 2008, 28(10):813-816.
|
| [5] |
RODEGHIERO F, TOSETTO A, ABSHIRE T, et al. ISTH/SSC bleeding assessment tool:a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders[J]. J Thromb Haemost, 2010, 8(9):2063-2065.
DOI
URL
|
| [6] |
KRUSE-JARRES R, JOHNSEN J M. How I treat type 2B von Willebrand disease[J]. Blood, 2018, 131(12):1292-1300.
DOI
URL
|
| [7] |
薛峰, 杨仁池. ASH ISTH NHF WFH 2021血管性血友病诊断指南解读[J]. 中华血液学杂志, 2021, 42(5):358-363.
|
| [8] |
SHARMA R, FLOOD V H. Advances in the diagnosis and treatment of von Willebrand disease[J]. Blood, 2017, 130(22):2386-2391.
DOI
URL
|
| [9] |
张威, 程大卫, 阮长耿. 血管性血友病因子的瑞斯托霉素辅因子定量测定[J]. 血栓与止血学杂志, 1994, 1(3):112-113.
|
| [10] |
KITCHEN S, JENNINGS I, WOODS T A, et al. Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers:results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation[J]. Semin Thromb Hemost, 2006, 32(5):492-498.
DOI
URL
|
| [11] |
SUCKER C, SENFT B, SCHARF R E, et al. Determination of von Willebrand factor activity:evaluation of the HaemosIL assay in comparison with established procedures[J]. Clin Appl Thromb Hemost, 2006, 12(3):305-310.
DOI
URL
|
| [12] |
DE VLEESCHAUWER A, DEVREESE K. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease[J]. Blood Coagul Fibrinolysis, 2006, 17(5):353-358.
DOI
URL
|
| [13] |
SAGHEER S, RODGERS S, YACOUB O, et al. Comparison of von Willebrand factor(VWF)activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry[J]. Haemophilia, 2016, 22(3):e200-e207.
|
| [14] |
熊立凡, 姚依婷, 王鸿利. 解读血管性血友病的治疗指南[J]. 内科理论与实践, 2012, 7(1):51-55.
|
)
